GSEA further showed that our murine Stat3-deficient KrasG12D tumours strongly correlate with a gene expression signature associated with human KRAS mutant lung tumours, and importantly, also with a poor prognosis-gene signature—more than Stat3-proficient KrasG12D tumours. This evidence concerns the gene KRAS and neoplasm.